Pfizer And Mylan Team Up For Generics Opportunity In Japan
This article was originally published in PharmAsia News
Executive Summary
As the Japanese government tries to boost generics utilization, Pfizer and Mylan plan to leverage combined strengths to become a market leader by 2015.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.